Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.10.5229

Relationships between Malignant Melanoma and Chromosome Damage in Human Peripheral Blood Lymphocytes  

Narin, Abdullah (Department of Biology, Faculty of Science, Istanbul University)
Tuncay, Orta (Department of Biology, Faculty of Science, Istanbul University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.10, 2012 , pp. 5229-5232 More about this Journal
Abstract
The incidence of malignant melanoma increases with age. One significiant effect of aging processes is an accumulation of oxidative damage in the genetical material. In this study, the relationship between malignant melanoma and damage in chromosomes and proliferative effectiveness of human peripheral lymphocytes were investigated by the micronucleus (MN) technique. A total of 15 malignant melanoma patients and appropriately matching 15 healthy controls were involved in the study. MN frequencies and proliferative indexes (PI) after non toxic levels of hydrogen peroxide treatment were also measured to determine damaging effect of oxidative stress in genome in addition to measuring the spontenous levels of micronuclei and PI. The patient group had a significantly higher rate of spontaneous MN than the control group (p<0.01). After treatment with $H_2O_2$, MN frequencies in the patient group was significantly decreased (p<0.01) although there was no difference between the treated and untreated results of control group (p=0.29). There was also difference (p<0.01) between the MN frequencies of the patient and the control group either in the spontaneous levels or in the $H_2O_2$ treated groups. The same significant difference persisted when the PI values were compared between patient and control groups. Increase in the MN frequency in patients could mean the alterations in the chromosomal structure which may lead to the chromosome instability and therefore genetic susceptibility to cancer. This increased number of micronuclei can also be used for cytological marker in identifying high risk cases for malignant melanoma.
Keywords
Cancer; malignant melanoma; micronuclei; lymphocytes; aging;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Berg-Drewniok B, Weichenthal M, Ehlert U, et al (1997). Increased spontaneous formation of micronuclei in cultured fibroblasts of first-degree relatives of familial melanoma patients. Cancer Genetics and Cytogenetics, 97, 106-110.   DOI
2 Boffetta P, Hel OV, Norppa H, et al (2007). Chromosomal aberrations and cancer risk: results of a cohort study from Central Europe. Am J Epidemiol, 165, 36-43.
3 Bolognesi C, Abbondandolo A, Barale R, et al (1997). Age related increase of baseline frequencies of sister chromatid exchanges, chromosome aberrations, and micronuclei in human lymphocytes. Cancer Epidemiol Biomarkers Prev, 6, 249-56.
4 Bonassi S, El-Zein R, Bolognesi C, Fenech M (2011). Micronuclei frequency in peripheral blood lymphocytes and cancer risk: evidence from human studies. Mutagenesis, 26, 93-100.   DOI
5 Bonassi S, Norppa H, Ceppi M, et al (2008). Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22 358 subjects in 11 countries. Carcinogenesis, 29, 1178-83.   DOI   ScienceOn
6 Bonassi S, Znaor A, Norppa H, Hagmar L (2004). Chromosomal aberrations and risk of cancer in humans: an epidemiologic perspective. Cytogenet Genome Res, 104, 376-82.   DOI
7 Boveri T, Fisher JG (1914). Zur Frage der Entstehung maligner Tumoren. Science, 40, 857-59.   DOI
8 Cardoso RS, Takahashi-Hyodo S, Peitl P Jr, Ghilardi-Neto T, Sakamoto- Hojo ET (2001). Evaluation of chromosomal aberrations,micronuclei and sister chromatid exchanges in hospital workers chronically exposed to ionizing radiation. Teratog Carcinog Mutagen, 21, 431-39.   DOI
9 Cho E, Rosner BA, Feskanich D, Colditz GA (2005). Risk factors and individual probabilities of melanoma for Whites. J Clin Oncol, In press.
10 Countryman PI, Heddle JA (1976). The Production of micronuclei from chromosome aberrations in irradiated cultures of human lymphocytes. Mutat Res, 41, 321-32.   DOI
11 Diepgen TL, Mahler V (2002). The epidemiology of skin cancer. Br J Dermatol, 146, 1-6.
12 Fenech M, Chang WP, Kirsch-Volders M, et al (2003). HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat Res, 534, 65-75.   DOI   ScienceOn
13 Geller AC, Miller DR, Annas GD, Demierre MF, Gilchrest BA (2002). Melanoma incidence and mortality among US Whites, 1969-1999. JAMA, 288, 1719-20.   DOI
14 Hagmar L, Brogger A, Hansteen IL, et al (1994). Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes. Nordic Study Group on the Health Risk of Chromosome Damage. Cancer Res, 54, 2919-22.
15 Helfand M, Mohon SM, Eden KB, Frame PS, Orleans CT (2001). Secreening for skin cancer. Am J Prev Med, 20, 47-58.
16 Iarmarcovai G, Ceppi M, Botta A, Orsiere T (2008). Micronüclei frequency in peripheral blood lymphocytes of cancer patients. A meta mnalysis. Mutat Res, 659, 274-83.   DOI   ScienceOn
17 Kazimirova A, Barancokova M, Dzupinkova Z, Wsolova L, Dusinska M (2009). Micronuclei and chromosomal aberrations, important markers of ageing: possible association with XPC and XPD polymorphisms. Mutat Res, 661, 35-40.   DOI
18 Knowles MA, Selby PJ (2005). Introduction to the cellular and molecular biology of cancer. In 'Oncogenes ', Ed Knowles MA. 4th ed. Oxford University Pres, Oxford (NY) Vol ??? 117-134.
19 Kolusayın Ozar MO, Orta T (2005). The use of chromosome aberrations in predicting breast cancer risk. J Exp. Clin Cancer Res, 24, 217-222.
20 McLean DI, Phillips N, Zhou Y, Gallagher R, Lee TK (2012). Year Trends in Skin Cancer in British Columbia, Canada, 1973 to 2003. J Cutan Med Surg, 16, 83-91.
21 Mensink HW, Vaarwater J, Keizer RJW et al (2011). Chromosomal aberrations in iris melanomas. Br J Ophthalmol, 95, 424-428.   DOI
22 Miguel J, Economos AC, Fleming J, Johnson JE (1980) Mitochondrial role in cell aging. Exp Gerontol, 15, 575-591.   DOI
23 Norppa H, Bonassi S, Hansteen IL, et al (2006). Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutat Res, 600, 37-45.   DOI
24 Norppa H, Falck GC (2003). What do human micronuclei contain? Mutagenesis, 18, 221-233.   DOI
25 Nowell PC, Hungerford DA (1960). A minute chromosome in human granulocytic leukemia. Science, 132, 1488-1501.   DOI
26 Oresajo C, Pillai S, Manco M, Yatskayer M, McDaniel D (2012). Antioxidants and the skin: U nderstanding formulation and efficacy. Dermatologic Therapy, 25, 252-9.   DOI
27 Rossner P, Boffetta P, Ceppi M, et al (2005). Chromosomal aberrations in lymphocytes of healthy subjects and risk of cancer. Environ Hlth Perspect, 113, 517-20.   DOI
28 Vanparys P, Vermeiren F, Sysmans M, Temmerman R (1990). The Micronucleus assay as a test for the detection of aneugenic activity. Mutat Res, 244, 95-103.   DOI   ScienceOn
29 Vodicka P, Polivkova Z, Sytarova S, et al (2010). Chromosomal damage in peripheral blood lymphocytes of newly diagnosed cancer patients and healthy controls. Carcinogenesis, 31, 1238-41.   DOI
30 Weichenthal M, Roser M, Ehlert U, et al (1989). Increased numbers of spontaneous micronuclei in blood lymphocytes and cultures fibroblasts of individuals with familial cutaneous malignant melanoma. J Cancer Res Clin Oncol, 115, 264-8.   DOI
31 Widel M, Dobrut M, Maka B, Lubecka B, Pluciennik A (1997). The Radiosensitivity of human malignant melanomas evaluated by cytokinesis-block micronucleus assay. Neoplasma, 44, 09-16.